Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.

NCT03491696 is registered in ClinicalTrials.gov with Centre Hospitalier Rouffach as lead sponsor.

NCT NCT03491696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03491696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.
Lead sponsor
Centre Hospitalier Rouffach
Phase
Phase 4
Overall status
Unknown status
Start date
December 22, 2018
Completion date
September 30, 2022
Enrollment
14 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder, hormone disturbance